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mortality rate (BSM) for 65 year old patients and frail 80 year old patients after debridement, resection arthroplasty, and reimplantation arthroplasty.
Study designs and other criteria for inclusion in the review
The study designs of the primary studies were not reported. However, preference was given to studies that used accepted clinical, pathological, and microbiological criteria and reported either the outcomes (separately) or follow-up time.
Sources searched to identify primary studies
The MEDLINE database was searched from January 1980 to June 1999. The keywords "prosthesis-related infections" and "hip" were used when searching MEDLINE. Manual searches of references and abstracts from major conferences were also used to identify relevant primary studies.
Criteria used to ensure the validity of primary studies
Not reported.
Methods used to judge relevance and validity, and for extracting data
Number of primary studies included
Twenty-five primary studies were used as sources of effectiveness evidence.
Methods of combining primary studies
The method of combination of primary studies was not reported. However, the best estimate within a plausible range of values obtained from the literature was selected.
Investigation of differences between primary studies
Results of the review
The results of the review were as follows:
The annual relapse rate was 30% (range: 15% -80%) after debridement, 3.5% (range: 0.6% -10%) after 2-stage exchange, and 30% (range: 15% -65%) while taking suppressive antibiotics. The probability of loosened prosthesis was 70% (range: 35% -90%).
The median time to reimplantation was 2 months (range: 1 -12 months).
The state utility was 0.93 (range: 0.70 -1) after total hip arthroplasty with good function and 0.60 (range: 0.5 -0.75) after resection arthroplasty.
The male and female BSM rates were:
For 65 year old patients: 0.5% (range: 0.3% -1%) and 0.4% (range: 0.2% -0.8%) after debridement, 1.2% (range: 0.6% -4%) and 1% (range: 0.7% -4%) after resection arthroplasty, 0.9% (range: 0.5% -2%) and 0.7% (range: 0.5% -3%) after reimplantation arthroplasty; and For frail 80 year old patients: 3% (range: 1% -4%) and 2% (range: 1% -3%) after debridement, 7% (range: 4% -9%) and 6% (range: 3% -9%) after resection arthroplasty, and 6% (range: 4% -7%) and 4% (range: 3% -6%) after reimplantation arthroplasty.
Measure of benefits used in the economic analysis
The benefit measures used in the economic analysis were life expectancy and quality-adjusted life years (QALYs). Valuation of health states was derived from published data and from some experts' opinions. Staff orthopaedic surgeons, reported to be familiar with THA management, were asked to rate by pain, mobility and self-care. These results were then transformed using the Health Utilisation Index, mark 2. Intermediate outcomes, important to decisionmakers, were also considered: the average number of operative procedures (obtained through a Monte Carlo simulation) and mean duration of relapse-free survival (time form first operative procedures to relapse infection or death).
Direct costs
A 3% discount rate was used. Quantities and unit costs were not reported separately. The costs included resection arthroplasty, reimplantation arthroplasty, debridement and retention, 6-week course of parenteral antibiotic therapy, oral suppressive antibiotics, and rehabilitation. The estimation of costs was based both on published data and on Medicare reimbursement charges. The total expected costs were calculated through the decision model. The price year was 1999.
Statistical analysis of costs
No statistical analysis of costs was reported.
Indirect Costs
Indirect costs (patient time) were calculated on the basis of the assumption that a patient could not work when immobilised. The 1999 wage rates for a person aged over 65 years were used. However, indirect costs were not included in the base case but only in the sensitivity analysis.
